| Agustin J Suarez, MD | |
|
1513 Mcneill Steephollow Rd, Carriere, MS 39426-9168 | |
| (601) 749-4503 | |
| Not Available |
| Full Name | Agustin J Suarez |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1513 Mcneill Steephollow Rd, Carriere, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528023900 | NPI | - | NPPES |
| 1349151 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 04335R (Louisiana) | Primary |
| Entity Name | St Tammany Parish Hospital Service District No 1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598798597 PECOS PAC ID: 0749273761 Enrollment ID: O20051102000003 |
News Archive
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
Hip replacement is one of the most frequent operations carried out in Germany. Each year, doctors implant some 200,000 artificial hip joints. Often the artificial hips need to be replaced just ten years later. In the future, a new implant currently being developed using high technology materials could help prevent premature revision surgeries.
Quantum Immunologics, Inc. (QI), a Florida-based company specializing in cancer immunotherapy, has recently filed two provisional patent applications relating to their work in cancer immunotherapy.
New research shows that people who have bariatric surgery to treat obesity report an overall improvement in quality of life issues after surgery, from their relationships to their medical conditions. Arizona State University researchers will present their findings at the 107th Annual Meeting of the American Sociological Association.
› Verified 4 days ago
| Entity Name | Northshore Oncology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609165711 PECOS PAC ID: 0648454603 Enrollment ID: O20110415000344 |
News Archive
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
Hip replacement is one of the most frequent operations carried out in Germany. Each year, doctors implant some 200,000 artificial hip joints. Often the artificial hips need to be replaced just ten years later. In the future, a new implant currently being developed using high technology materials could help prevent premature revision surgeries.
Quantum Immunologics, Inc. (QI), a Florida-based company specializing in cancer immunotherapy, has recently filed two provisional patent applications relating to their work in cancer immunotherapy.
New research shows that people who have bariatric surgery to treat obesity report an overall improvement in quality of life issues after surgery, from their relationships to their medical conditions. Arizona State University researchers will present their findings at the 107th Annual Meeting of the American Sociological Association.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Agustin J Suarez, MD 1513 Mcneill Steephollow Rd, Carriere, MS 39426-9168 Ph: (601) 749-4503 | Agustin J Suarez, MD 1513 Mcneill Steephollow Rd, Carriere, MS 39426-9168 Ph: (601) 749-4503 |
News Archive
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
Hip replacement is one of the most frequent operations carried out in Germany. Each year, doctors implant some 200,000 artificial hip joints. Often the artificial hips need to be replaced just ten years later. In the future, a new implant currently being developed using high technology materials could help prevent premature revision surgeries.
Quantum Immunologics, Inc. (QI), a Florida-based company specializing in cancer immunotherapy, has recently filed two provisional patent applications relating to their work in cancer immunotherapy.
New research shows that people who have bariatric surgery to treat obesity report an overall improvement in quality of life issues after surgery, from their relationships to their medical conditions. Arizona State University researchers will present their findings at the 107th Annual Meeting of the American Sociological Association.
› Verified 4 days ago
Ahmad A Haidar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Country Club Rd, Carriere, MS 39426 Phone: 601-799-4777 Fax: 601-799-0052 |